Reported number of people receiving antiretroviral therapy in Ecuador
Ecuador: Reported number of people receiving antiretroviral therapy was 47,080 in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Ecuador, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for reported number of people receiving antiretroviral therapy in Ecuador is 47,080, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 9.8% on the previous year and up 203.9% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Ecuador peaked at 47,080 in 2025 and was at its lowest, 337, in 2000.
That places Ecuador 55th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Ecuador, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 337 | — |
| 2001 | 358 | +6.2% |
| 2002 | 379 | +5.9% |
| 2003 | 400 | +5.5% |
| 2004 | 801 | +100.2% |
| 2005 | 1,201 | +49.9% |
| 2006 | 1,802 | +50.0% |
| 2007 | 2,763 | +53.3% |
| 2008 | 4,102 | +48.5% |
| 2009 | 5,447 | +32.8% |
| 2010 | 7,168 | +31.6% |
| 2011 | 8,947 | +24.8% |
| 2012 | 9,396 | +5.0% |
| 2013 | 10,873 | +15.7% |
| 2014 | 12,624 | +16.1% |
| 2015 | 15,491 | +22.7% |
| 2016 | 18,275 | +18.0% |
| 2017 | 21,526 | +17.8% |
| 2018 | 25,148 | +16.8% |
| 2019 | 30,812 | +22.5% |
| 2020 | 33,797 | +9.7% |
| 2021 | 34,538 | +2.2% |
| 2022 | 38,270 | +10.8% |
| 2023 | 40,971 | +7.1% |
| 2024 | 42,882 | +4.7% |
| 2025 | 47,080 | +9.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1,759 | 337 | 5,447 | 10 |
| 2010s | 16,026 | 7,168 | 30,812 | 10 |
| 2020s | 39,590 | 33,797 | 47,080 | 6 |
Countries ranked near Ecuador
More health data for Ecuador
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6766 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,324 deaths per 1,000 people (2090)
- Number of infants who die before age 1 354 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0362 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Ecuador?
- Reported number of people receiving antiretroviral therapy in Ecuador was 47,080 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Ecuador?
- The highest recorded value was 47,080 in 2025.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Ecuador?
- The lowest recorded value was 337 in 2000.
- How does Ecuador rank for reported number of people receiving antiretroviral therapy?
- Ecuador ranks 55th out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Ecuador?
- Over the last ten years it is up 203.9%. The long-run trend across the full record is volatile.
- Where does this Ecuador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).